Government announces largest health care fraud settlement in U.S. history; GlaxoSmithKline, LLC, enters corporate integrity agreement with novel provisions *

USA - July 11 2012
Yesterday, the U.S. Department of Justice announced that GlaxoSmithKline, LLC (“GSK”), would pay $3 billion in criminal and civil penalties to resolve multiple investigations into the company’s sales, marketing and pricing practices for nine of its drugs.

Co-authors: Gary C. Messplay, D. Kyle Sampson, Sheldon T. Bradshaw.